Page last updated: 2024-12-07

1,1,2-trichloroethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,1,2-trichloroethanol, also known as **chloral hydrate**, is a hypnotic drug that was historically used as a sedative and sleep aid. It's no longer widely used in medicine due to its potential for addiction and toxicity.

Here's why 1,1,2-trichloroethanol is still relevant for research:

**1. Historical Significance:** Chloral hydrate was the first synthetic hypnotic to be discovered, and its development marked a significant milestone in the history of medicine.

**2. Pharmacological Model:** It acts as a **GABAA receptor agonist**, which means it enhances the effects of the neurotransmitter GABA. This makes it a useful tool for researchers studying the GABAergic system, which plays a crucial role in anxiety, sleep, and seizures.

**3. Effects on Cell Processes:** Chloral hydrate has been shown to affect various cellular processes, including protein synthesis, DNA replication, and cell cycle regulation. Researchers use it to study these processes and their potential implications for disease.

**4. Drug Development:** Understanding the mechanism of action of chloral hydrate can inform the development of new drugs targeting the GABAergic system.

**5. Toxicological Studies:** Its toxicity and potential for addiction are valuable subjects of study in toxicology research, providing insights into the mechanisms of drug abuse and the development of safe and effective medications.

**However, it's important to note that 1,1,2-trichloroethanol is a controlled substance and should only be used under strict laboratory conditions with appropriate safety measures.**

**Here are some additional points to consider:**

* 1,1,2-trichloroethanol has been used in various research fields, including neurology, pharmacology, toxicology, and even environmental science.
* It is often used in animal models to study its effects on sleep, anxiety, and other behavioral responses.
* Its use in research is strictly regulated, and researchers must adhere to ethical guidelines and safety protocols.

Ultimately, while 1,1,2-trichloroethanol is no longer used clinically, its role in research continues to be significant for understanding the GABAergic system, drug development, and the mechanisms of toxicity.

1,1,2-trichloroethanol: metabolite of 1,1,2-trichloroethylene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119427
CHEMBL ID449666
SCHEMBL ID134202
MeSH IDM0130141

Synonyms (11)

Synonym
13287-89-3
1,1,2-trichloroethanol
CHEMBL449666
1,2,2-trichloroethanol
ethanol, 1,2,2-trichloro-
SCHEMBL134202
NIBKDWIGIKUFKL-UHFFFAOYSA-N
trichloro ethanol
2-trichloroethanol
DTXSID10927850
1,2,2-trichloroethan-1-ol

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In addition, each of the metabolites tested were significantly less developmental toxic than the parent compound, trichloroethylene."( Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
Bantle, JA; Fort, DJ; Hull, M; Rayburn, JR; Stover, EL, 1993
)
0.29

Dosage Studied

ExcerptRelevanceReference
" Multiple dosing of chloral hydrate in preterm infants should be used with caution and frequent monitoring of serum bilirubin concentrations is indicated in such cases."( Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations.
Gorecki, DK; Hindmarsh, KW; Kasian, GF; Reimche, LD; Sankaran, K; Tan, L, 1989
)
0.28
" Fischer 344 rats and beagle dogs were dosed orally with TRI and blood was analyzed for TRI, DCA, TCA, and trichloroethanol (TCE)."( Factors affecting species differences in the kinetics of metabolites of trichloroethylene.
Bonate, PL; Bull, RJ; Stenner, RD; Stevens, DK; Templin, MV; Tuman, D, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409943Inhibition of human recombinant MAOB by fluorimetric method2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409942Inhibition of human recombinant MAOA by fluorimetric method2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (54.55)18.7374
1990's4 (36.36)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.55 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]